Combining in silico models with in vivo validation of tumor gene expression suggested a mechanism for melanoma immune evasion based on production of TNF-α by the tumor, whereby a positive feedback loop induced by TNF-α signaling allows for small tumors with negligible TNF-α production and large tumors producing significant amounts of the cytokine. The gene discussed is TNF; the disease is neoplasm.